Page last updated: 2024-10-20

pyridoxine and Genetic Predisposition

pyridoxine has been researched along with Genetic Predisposition in 15 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Research Excerpts

ExcerptRelevanceReference
"Hand-foot syndrome (HFS) is a common adverse effect of capecitabine treatment."9.24Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial. ( Chay, WY; Chia, JWK; Choo, SP; Dent, RA; Koh, KX; Koo, WH; Kwok, LL; Lo, SK; Loh, M; Mok, ZY; Ng, RCH; Soong, RCT; Syn, N; Tan, S; Tham, CK; Toh, HC; Wong, NS; Yap, YS, 2017)
"Homocystinuria (HCU) due to cystathionine beta-synthase (CBS) deficiency leads to severe hyperhomocysteinemia (HHcy)."8.80Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. ( Boers, GH; Naughten, ER; Wilcken, B; Wilcken, DE; Yap, S, 2000)
"Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by intractable seizures in neonates and infants."7.81First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene. ( Bojidarova, M; Georgieva, B; Georgieva, R; Kadiyska, T; Litvinenko, I; Mitev, V; Stamatov, D; Tacheva, G; Tincheva, S; Todorov, T; Todorova, A; Yordanova, I, 2015)
"Pyridoxine-dependent epilepsy is a disorder associated with severe seizures that may be caused by deficient activity of α-aminoadipic semialdehyde dehydrogenase, encoded by the ALDH7A1 gene, with accumulation of α-aminoadipic semialdehyde and piperideine-6-carboxylic acid."7.76The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1. ( Brocker, C; Creadon-Swindell, G; Gallagher, RC; Scharer, G; Spector, E; Van Hove, JL; Vasiliou, V, 2010)
"Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis."7.70Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999)
"Hand-foot syndrome (HFS) is a common adverse effect of capecitabine treatment."5.24Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial. ( Chay, WY; Chia, JWK; Choo, SP; Dent, RA; Koh, KX; Koo, WH; Kwok, LL; Lo, SK; Loh, M; Mok, ZY; Ng, RCH; Soong, RCT; Syn, N; Tan, S; Tham, CK; Toh, HC; Wong, NS; Yap, YS, 2017)
"Homocystinuria (HCU) due to cystathionine beta-synthase (CBS) deficiency leads to severe hyperhomocysteinemia (HHcy)."4.80Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy. ( Boers, GH; Naughten, ER; Wilcken, B; Wilcken, DE; Yap, S, 2000)
"Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by intractable seizures in neonates and infants."3.81First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene. ( Bojidarova, M; Georgieva, B; Georgieva, R; Kadiyska, T; Litvinenko, I; Mitev, V; Stamatov, D; Tacheva, G; Tincheva, S; Todorov, T; Todorova, A; Yordanova, I, 2015)
"Pyridoxine-dependent epilepsy is a disorder associated with severe seizures that may be caused by deficient activity of α-aminoadipic semialdehyde dehydrogenase, encoded by the ALDH7A1 gene, with accumulation of α-aminoadipic semialdehyde and piperideine-6-carboxylic acid."3.76The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1. ( Brocker, C; Creadon-Swindell, G; Gallagher, RC; Scharer, G; Spector, E; Van Hove, JL; Vasiliou, V, 2010)
"Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis."3.70Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999)
"The aim of this study was to investigate a possible association among the thermolabile polymorphism, nucleotide 677 cytosine to thymidine point mutation (677 C-->T) of the methylenetetrahydrofolate reductase (MTHFR) gene, hyperhomocysteinemia, serum folate, vitamins B12 and B6, and stroke in children."3.70Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. ( Artuch, R; Campistol, J; Cardo, E; Colomé, C; Monrós, E; Pineda, M; Vilaseca, MA, 2000)
"Early onset hypotonia, oculogyric crises, and autonomic symptoms such as excessive sweating, nasal congestion and profuse nasal, and oropharyngeal secretions, were common in our patients."1.56The genetic and clinical characteristics of aromatic L-amino acid decarboxylase deficiency in mainland China. ( Bao, X; Chen, Y; Wang, J; Wen, Y; Zhang, Q, 2020)
"Seizures are typically not responsive to conventional antiepileptic drugs, but they cease after parental pyridoxine administration."1.46Pyridoxine dependent epilepsies: new therapeutical point of view. ( Corsello, G; Falsaperla, R, 2017)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's4 (26.67)29.6817
2010's8 (53.33)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Wen, Y1
Wang, J1
Zhang, Q1
Chen, Y1
Bao, X1
Plecko, B1
Zweier, M1
Begemann, A1
Mathis, D1
Schmitt, B1
Striano, P1
Baethmann, M1
Vari, MS1
Beccaria, F1
Zara, F1
Crowther, LM1
Joset, P1
Sticht, H1
Papuc, SM1
Rauch, A1
Yap, YS1
Kwok, LL1
Syn, N1
Chay, WY1
Chia, JWK1
Tham, CK1
Wong, NS1
Lo, SK1
Dent, RA1
Tan, S1
Mok, ZY1
Koh, KX1
Toh, HC1
Koo, WH1
Loh, M1
Ng, RCH1
Choo, SP1
Soong, RCT1
Falsaperla, R1
Corsello, G1
Creasey, T1
Biss, T1
Lambert, J1
Smith, F1
Clark, B1
Carey, P1
Poloni, S1
Sperb-Ludwig, F1
Borsatto, T1
Weber Hoss, G1
Doriqui, MJR1
Embiruçu, EK1
Boa-Sorte, N1
Marques, C1
Kim, CA1
Fischinger Moura de Souza, C1
Rocha, H1
Ribeiro, M1
Steiner, CE1
Moreno, CA1
Bernardi, P1
Valadares, E1
Artigalas, O1
Carvalho, G1
Wanderley, HYC1
Kugele, J1
Walter, M1
Gallego-Villar, L1
Blom, HJ1
Schwartz, IVD1
Sharawat, IK1
Kasinathan, A1
Sahu, JK1
Sankhyan, N1
Tincheva, S1
Todorov, T1
Todorova, A1
Georgieva, R1
Stamatov, D1
Yordanova, I1
Kadiyska, T1
Georgieva, B1
Bojidarova, M1
Tacheva, G1
Litvinenko, I1
Mitev, V1
Almeida, OP1
McCaul, K1
Hankey, GJ1
Norman, P1
Jamrozik, K1
Flicker, L1
Scharer, G1
Brocker, C1
Vasiliou, V1
Creadon-Swindell, G1
Gallagher, RC1
Spector, E1
Van Hove, JL1
McQuillan, BM1
Beilby, JP1
Nidorf, M1
Thompson, PL1
Hung, J1
de Jong, SC1
Stehouwer, CD1
van den Berg, M1
Kostense, PJ1
Alders, D1
Jakobs, C1
Pals, G1
Rauwerda, JA1
Cardo, E1
Monrós, E1
Colomé, C1
Artuch, R1
Campistol, J1
Pineda, M1
Vilaseca, MA1
Boers, GH2
Yap, S1
Naughten, ER1
Wilcken, B1
Wilcken, DE1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Double-Blind Placebo-Controlled Trial of Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome (HFS)[NCT00486213]Phase 3210 participants (Actual)Interventional2007-06-30Terminated (stopped due to Slow accrual)
Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine: A Randomized Controlled Trial.[NCT05641246]Phase 266 participants (Anticipated)Interventional2022-12-08Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for pyridoxine and Genetic Predisposition

ArticleYear
Homocysteine and depression in later life.
    Archives of general psychiatry, 2008, Volume: 65, Issue:11

    Topics: Age Factors; Aged; Cohort Studies; Depressive Disorder; Folic Acid; Genetic Predisposition to Diseas

2008
Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease.
    Seminars in thrombosis and hemostasis, 2000, Volume: 26, Issue:3

    Topics: Arteriosclerosis; Case-Control Studies; Clinical Trials as Topic; Comorbidity; Coronary Disease; Fol

2000
Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.
    Seminars in thrombosis and hemostasis, 2000, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Aged; Australia; Child; Child, Preschool; Cohort Studies; Cystine; Drug Resistanc

2000

Trials

1 trial available for pyridoxine and Genetic Predisposition

ArticleYear
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
    JAMA oncology, 2017, Nov-01, Volume: 3, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ

2017
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
    JAMA oncology, 2017, Nov-01, Volume: 3, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ

2017
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
    JAMA oncology, 2017, Nov-01, Volume: 3, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ

2017
Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial.
    JAMA oncology, 2017, Nov-01, Volume: 3, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Asian People; Capecitabine; Chi-Squ

2017

Other Studies

11 other studies available for pyridoxine and Genetic Predisposition

ArticleYear
The genetic and clinical characteristics of aromatic L-amino acid decarboxylase deficiency in mainland China.
    Journal of human genetics, 2020, Volume: 65, Issue:9

    Topics: Alleles; Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; China; Cohort S

2020
Confirmation of mutations in
    Journal of medical genetics, 2017, Volume: 54, Issue:12

    Topics: Adolescent; Adult; Alleles; Child; Child, Preschool; Consanguinity; DNA Mutational Analysis; Electro

2017
Pyridoxine dependent epilepsies: new therapeutical point of view.
    Italian journal of pediatrics, 2017, Aug-05, Volume: 43, Issue:1

    Topics: Anticonvulsants; Brain Diseases, Metabolic; Child, Preschool; Electroencephalography; Epilepsy; Fema

2017
Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis.
    British journal of haematology, 2018, Volume: 180, Issue:1

    Topics: 5-Aminolevulinate Synthetase; Alleles; Anemia, Sideroblastic; Child, Preschool; Erythrocytes; Genes,

2018
CBS mutations are good predictors for B6-responsiveness: A study based on the analysis of 35 Brazilian Classical Homocystinuria patients.
    Molecular genetics & genomic medicine, 2018, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Alleles; Base Sequence; Biomarkers, Pharmacological; Brazil; Child; Cystathionine

2018
Response to Carbamazepine in KCNQ2 Related Early Infantile Epileptic Encephalopathy.
    Indian journal of pediatrics, 2019, Volume: 86, Issue:3

    Topics: Carbamazepine; Electroencephalography; Exons; Genetic Predisposition to Disease; Humans; KCNQ2 Potas

2019
First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:12

    Topics: Aldehyde Dehydrogenase; Anticonvulsants; Bulgaria; Child; Child, Preschool; Dietary Supplements; DNA

2015
The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.
    Journal of inherited metabolic disease, 2010, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Aldehyde Dehydrogenase; Anticonvulsants; Child; Child, Preschool; Colorado; Devel

2010
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
    Circulation, 1999, May-11, Volume: 99, Issue:18

    Topics: Adult; Aged; Amino Acid Substitution; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Comorbid

1999
Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:5

    Topics: Adult; Age Factors; Amino Acid Substitution; Arteriosclerosis; Body Mass Index; Comorbidity; Fasting

1999
Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status.
    Journal of child neurology, 2000, Volume: 15, Issue:5

    Topics: Adolescent; Case-Control Studies; Child; Child, Preschool; Cytosine; Female; Folic Acid; Genetic Pre

2000